Savoir Faire Capital Management L.P. Sells 25,186 Shares of The Clorox Company (NYSE:CLX)

Savoir Faire Capital Management L.P. cut its position in The Clorox Company (NYSE:CLX) by 44.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 31,815 shares of the company’s stock after selling 25,186 shares during the quarter. Clorox comprises 2.6% of Savoir Faire Capital Management L.P.’s portfolio, making the stock its 16th biggest holding. Savoir Faire Capital Management L.P.’s holdings in Clorox were worth $5,183,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in CLX. Mizuho Securities USA LLC raised its position in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Van ECK Associates Corp raised its position in shares of Clorox by 1,715.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after buying an additional 1,380,724 shares in the last quarter. Nuance Investments LLC raised its position in shares of Clorox by 150.6% in the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after buying an additional 960,094 shares in the last quarter. Wulff Hansen & CO. raised its position in shares of Clorox by 13,547.0% in the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock valued at $60,063,000 after buying an additional 436,891 shares in the last quarter. Finally, International Assets Investment Management LLC raised its position in shares of Clorox by 424.9% in the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after buying an additional 435,971 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.57% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CLX shares. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Barclays upped their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their price objective for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $155.00.

Clorox Stock Up 0.9 %

Shares of NYSE CLX opened at $169.14 on Tuesday. The firm has a market cap of $20.94 billion, a PE ratio of 58.93, a P/E/G ratio of 3.10 and a beta of 0.41. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $169.21. The company’s fifty day simple moving average is $162.53 and its 200 day simple moving average is $147.73. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue was up 27.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 earnings per share. As a group, sell-side analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.89%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.